Canada on February 26 approved AstraZeneca’s Covid-19 vaccine, including the version produced by the Serum Institute of India, and 500,000 doses are due to arrive
The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc
The Covishield vaccine manufactured in India has reached Brazil after the country flew in a plane to fetch 2 million doses of the coronavirus vaccine.
Serum Institute of India, the world’s largest vaccine producer, has said it has made 40 million doses of AstraZeneca’s potential COVID-19 vaccine, and will soon
The late-phase human clinical trials of the Oxford- AstraZeneca vaccine, which is also known as Covishield in India, is giving hopeful results and have not
The Serum Institute of India (SII) will produce an additional 10 crore doses of Covid-19 vaccine for India and, low and middle-income countries in 2021.
The COVID-19 tally in India continued to record a massive surge with 97,894 cases being registered in a single day. While the overall tally gone
K. ARAVIND The stock market was very volatile last week. The main reason for this was the petition before the Supreme Court seeking the waiver
India recorded 67,151 new cases of the novel coronavirus and 1,059 deaths. This takes the country’s tally to 32, 34,475 COVID-19 cases including 7,07,267 patients
The COVID-19 vaccine designed and developed by Oxford University and UK-based biopharma company AstraZeneca will cost under Rs 1000 per shot in India. The price
